SecBot SecBot

URSB

URSB Bancorp, Inc.
OTC· CIK 0002084261
$13.04 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $13.04
Since first trade
+21.9%
from $10.70 · Mar 27
30 days
+1.1%
from $12.90
Range since listing
$10.65–13.04
0% from high · low Mar 30
Avg volume 20D
1.9K
Oct 5 spike 10.5K
Short interest
506
Days to cover
1.0
at average volume
Insider net
+$5.7K
1 buyer · 0 sellers · 12 mo
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 2 reports · 90 days
Balance 0 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/2
Strongest NEUTRAL Lawrence B. Seidman and affiliated entities filed an amendment to their Schedule 13D, increasing their…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Apr 30 Short interest jumps 387.5% to 39
  • X May 15 Short interest falls 79.5% to 8
  • X May 29 Short interest jumps 2725.0% to 226
  • B Jun 8 1 insider buy $5.7K at $11.37
  • X Jun 15 Short interest falls 78.8% to 48

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $5.7K at an average $11.37. No open-market sales. Price is 15% above their cost.

  • TrendUPTREND

    2% above its 50-day average. New closing high $13.04 on Oct 26.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
Lawrence B. Seidman and affiliated entities filed an amendment to their Schedule 13D, increasing their aggregate…
SC 13D/A — Impact 4/10
Sep 23, 2026 SEC
Lawrence B. Seidman and affiliated entities filed a Schedule 13D disclosing a 5.40% beneficial ownership stake in URSB…
SC 13D — Impact 5/10
Jun 26, 2026 SEC
URSB Bancorp appointed Michael L. Hammer to its Board of Directors and the board of its bank subsidiary, effective…
8-K — Impact 2/10
Jun 8, 2026 Insider
Kwasnik John F. bought 500 shares
Director @ $11.37 ($5.7K)
Mar 31, 2026 Short interest
FTD: URSB — 182,478 shares ($1.9M) failed to deliver
Settlement: 20260331, Price: $10.65, FTD Value: $1,943,390.7, URSB BANCORP INC COM
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Mar 31, 2026
Short interest
FTD: URSB — 182,478 shares ($1.9M) failed to deliver
Settlement: 20260331, Price: $10.65, FTD Value: $1,943,390.7, URSB BANCORP INC COM
Mar 30, 2026
Short interest
FTD: URSB — 203,046 shares ($2.2M) failed to deliver
Settlement: 20260330, Price: $10.70, FTD Value: $2,172,592.2, URSB BANCORP INC COM

Insider ledger

Form 4
$5.7K
bought · 1 insider
$0
sold · 0 insiders
+14.7%
vs their $11.37 cost
DateInsiderTypeValue
Jun 8, 2026
Kwasnik John F.
Director
BUY$5.7K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
506
shares short
1.0
days to cover

SecBot reports

3 filings · 1 bullish · 0 bearish · 2 neutral
All URSB filing & press-release reports (3)